lactic acid has been researched along with Choroid Neovascularization in 13 studies
Lactic Acid: A normal intermediate in the fermentation (oxidation, metabolism) of sugar. The concentrated form is used internally to prevent gastrointestinal fermentation. (From Stedman, 26th ed)
2-hydroxypropanoic acid : A 2-hydroxy monocarboxylic acid that is propanoic acid in which one of the alpha-hydrogens is replaced by a hydroxy group.
| Excerpt | Relevance | Reference |
|---|---|---|
| "Lactic acid concentration was measured in the RPE-choroid region." | 1.48 | Lactic Acid Upregulates VEGF Expression in Macrophages and Facilitates Choroidal Neovascularization. ( Che, JH; Cho, CS; Chung, H; Jung, D; Kim, JH; Lee, K; Na, YR; Park, JH; Park, SW; Quan, H; Seok, SH; Song, J, 2018) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 3 (23.08) | 29.6817 |
| 2010's | 9 (69.23) | 24.3611 |
| 2020's | 1 (7.69) | 2.80 |
| Authors | Studies |
|---|---|
| Lambert, V | 1 |
| Hansen, S | 1 |
| Schoumacher, M | 1 |
| Lecomte, J | 1 |
| Leenders, J | 1 |
| Hubert, P | 1 |
| Herfs, M | 1 |
| Blacher, S | 1 |
| Carnet, O | 1 |
| Yip, C | 1 |
| Blaise, P | 1 |
| Duchateau, E | 1 |
| Locht, B | 1 |
| Thys, M | 1 |
| Cavalier, E | 1 |
| Gothot, A | 1 |
| Govaerts, B | 1 |
| Rakic, JM | 1 |
| Noel, A | 1 |
| de Tullio, P | 1 |
| Song, J | 1 |
| Lee, K | 1 |
| Park, SW | 1 |
| Chung, H | 1 |
| Jung, D | 1 |
| Na, YR | 1 |
| Quan, H | 1 |
| Cho, CS | 1 |
| Che, JH | 1 |
| Kim, JH | 1 |
| Park, JH | 1 |
| Seok, SH | 1 |
| Shmueli, RB | 1 |
| Ohnaka, M | 1 |
| Miki, A | 1 |
| Pandey, NB | 1 |
| Lima e Silva, R | 1 |
| Koskimaki, JE | 1 |
| Kim, J | 1 |
| Popel, AS | 1 |
| Campochiaro, PA | 2 |
| Green, JJ | 1 |
| Varshochian, R | 2 |
| Jeddi-Tehrani, M | 2 |
| Mahmoudi, AR | 2 |
| Khoshayand, MR | 1 |
| Atyabi, F | 2 |
| Sabzevari, A | 2 |
| Esfahani, MR | 1 |
| Dinarvand, R | 2 |
| Riazi-Esfahani, M | 1 |
| Aghazadeh, S | 1 |
| Mahbod, M | 1 |
| Movassat, M | 1 |
| Gaddipati, S | 1 |
| Lu, Q | 2 |
| Kasetti, RB | 1 |
| Miller, MC | 1 |
| Trent, JO | 1 |
| Kaplan, HJ | 1 |
| Li, Q | 1 |
| Chu, Y | 1 |
| Chen, N | 1 |
| Yu, H | 1 |
| Mu, H | 1 |
| He, B | 1 |
| Hua, H | 1 |
| Wang, A | 1 |
| Sun, K | 1 |
| Vargas, A | 1 |
| Delie, F | 1 |
| Kim, H | 1 |
| Csaky, KG | 1 |
| Jin, J | 1 |
| Zhou, KK | 1 |
| Park, K | 1 |
| Hu, Y | 1 |
| Xu, X | 1 |
| Zheng, Z | 1 |
| Tyagi, P | 1 |
| Kompella, UB | 2 |
| Ma, JX | 1 |
| Pan, CK | 1 |
| Durairaj, C | 1 |
| Agwu, O | 1 |
| Oliver, SC | 1 |
| Quiroz-Mercado, H | 1 |
| Mandava, N | 1 |
| Olson, JL | 1 |
| Saishin, Y | 2 |
| Silva, RL | 1 |
| Callahan, K | 1 |
| Schoch, C | 1 |
| Ahlheim, M | 1 |
| Lai, H | 1 |
| Kane, F | 1 |
| Brazzell, RK | 1 |
| Bodmer, D | 1 |
| Xu, J | 1 |
| Wang, Y | 1 |
| Li, Y | 1 |
| Yang, X | 1 |
| Zhang, P | 1 |
| Hou, H | 1 |
| Shi, Y | 1 |
| Song, C | 1 |
13 other studies available for lactic acid and Choroid Neovascularization
| Article | Year |
|---|---|
Pyruvate dehydrogenase kinase/lactate axis: a therapeutic target for neovascular age-related macular degeneration identified by metabolomics.
Topics: Angiogenesis Inhibitors; Biomarkers; Choroidal Neovascularization; Disease Management; Humans; Lacti | 2020 |
Lactic Acid Upregulates VEGF Expression in Macrophages and Facilitates Choroidal Neovascularization.
Topics: Animals; Cells, Cultured; Choroid; Choroidal Neovascularization; Disease Models, Animal; Enzyme-Link | 2018 |
Long-term suppression of ocular neovascularization by intraocular injection of biodegradable polymeric particles containing a serpin-derived peptide.
Topics: Animals; Biocompatible Materials; Biodegradation, Environmental; Choroidal Neovascularization; Endot | 2013 |
The protective effect of albumin on bevacizumab activity and stability in PLGA nanoparticles intended for retinal and choroidal neovascularization treatments.
Topics: Angiogenesis Inhibitors; Animals; Antibodies, Monoclonal, Humanized; Bevacizumab; Choroidal Neovascu | 2013 |
Albuminated PLGA nanoparticles containing bevacizumab intended for ocular neovascularization treatment.
Topics: Albumins; Animals; Bevacizumab; Choroidal Neovascularization; Delayed-Action Preparations; Lactic Ac | 2015 |
IKK2 inhibition using TPCA-1-loaded PLGA microparticles attenuates laser-induced choroidal neovascularization and macrophage recruitment.
Topics: Amides; Animals; Choroidal Neovascularization; Disease Models, Animal; Drug Carriers; Female; I-kapp | 2015 |
Topical ocular delivery to laser-induced choroidal neovascularization by dual internalizing RGD and TAT peptide-modified nanoparticles.
Topics: Administration, Ophthalmic; Administration, Topical; Animals; Cells, Cultured; Choroidal Neovascular | 2017 |
Potential use of biodegradable nanoparticles for the photodynamic therapy of eye diseases.
Topics: Animals; Biotransformation; Chick Embryo; Chorioallantoic Membrane; Choroidal Neovascularization; Co | 2009 |
Nanoparticle-integrin antagonist C16Y peptide treatment of choroidal neovascularization in rats.
Topics: Animals; Choroidal Neovascularization; Fluorescein Angiography; Humans; Integrins; Lactic Acid; Macu | 2010 |
Anti-inflammatory and antiangiogenic effects of nanoparticle-mediated delivery of a natural angiogenic inhibitor.
Topics: Angiogenesis Inhibitors; Animals; Anti-Inflammatory Agents; Blotting, Western; Capillary Permeabilit | 2011 |
Comparison of long-acting bevacizumab formulations in the treatment of choroidal neovascularization in a rat model.
Topics: Angiogenesis Inhibitors; Animals; Antibodies, Monoclonal; Antibodies, Monoclonal, Humanized; Bevaciz | 2011 |
Periocular injection of microspheres containing PKC412 inhibits choroidal neovascularization in a porcine model.
Topics: Animals; Biocompatible Materials; Biological Availability; Bruch Membrane; Choroid; Choroidal Neovas | 2003 |
Inhibitory efficacy of intravitreal dexamethasone acetate-loaded PLGA nanoparticles on choroidal neovascularization in a laser-induced rat model.
Topics: Animals; Choroidal Neovascularization; Chromatography, High Pressure Liquid; Delayed-Action Preparat | 2007 |